- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/195 - Radicals derived from nitrogen analogues of carboxylic acids
Patent holdings for IPC class C07D 295/195
Total number of patents in this class: 93
10-year publication summary
|
9
|
10
|
8
|
9
|
2
|
6
|
4
|
8
|
4
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Reata Pharmaceuticals Holdings, LLC | 52 |
7 |
| The General Hospital Corporation | 4858 |
6 |
| Massachusetts Institute of Technology | 10239 |
5 |
| The Broad Institute, Inc. | 1975 |
5 |
| President and Fellows of Harvard College | 6091 |
3 |
| Concentric Analgesics, Inc. | 11 |
3 |
| Rhizen Pharmaceuticals AG | 57 |
3 |
| Bristol-myers Squibb Company | 4729 |
2 |
| Ricoh Company, Ltd. | 13346 |
2 |
| University of Florida Research Foundation, Inc. | 4173 |
2 |
| Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences | 75 |
2 |
| Northeastern University | 1292 |
2 |
| Novira Therapeutics, Inc. | 32 |
2 |
| Oryzon Genomics S.A. | 103 |
2 |
| Recordati Industria Chimica e Farmaceutica S.p.A. | 53 |
2 |
| United Therapeutics Corporation | 330 |
2 |
| University of Virginia Patent Foundation | 1639 |
2 |
| Virginia Tech Intellectual Properties, Inc. | 948 |
2 |
| Wisorig Technologies Pte. Limited | 10 |
2 |
| Shanghai Wennai Therapeutics Co Ltd | 4 |
2 |
| Other owners | 35 |